Development and validation of the Multimorbidity Treatment Burden Questionnaire (MTBQ)

Objective To develop and validate a new scale to assess treatment burden (the effort of looking after one’s health) for patients with multimorbidity. Design Mixed-methods. Setting UK primary care. Participants Content of the Multimorbidity Treatment Burden Questionnaire (MTBQ) was based on a literature review and views from a patient and public involvement group. Face validity was assessed through cognitive interviews. The scale was piloted and the final version was tested in 1546 adults with multimorbidity (mean age 71 years) who took part in the 3D Study, a cluster randomised controlled trial. For each question, we examined the proportion of missing data and the distribution of responses. Factor analysis, Cronbach’s alpha, Spearman’s rank correlations and longitudinal regression assessed dimensional structure, internal consistency reliability, construct validity and responsiveness, respectively. We assessed interpretability by grouping the global MTBQ scores into zero and tertiles (>0) and comparing participant characteristics across these categories. Results Cognitive interviews found good acceptability and content validity. Factor analysis supported a one-factor solution. Cronbach’s alpha was 0.83, indicating internal consistency reliability. The MTBQ score had a positive association with a comparator treatment burden scale (rs 0.58, P<0.0001) and with self-reported disease burden (rs 0.43, P<0.0001), and a negative association with quality of life (rs−0.36, P<0.0001) and self-rated health (rs−0.36, P<0.0001). Female participants, younger participants and participants with mental health conditions were more likely to have high treatment burden scores. Changes in MTBQ score over 9-month follow-up were associated, as expected, with changes in measures of quality of life (EuroQol five dimensions, five level questionnaire) and patient-centred care (Patient Assessment of Chronic Illness Care). Conclusion The MTBQ is a 10-item measure of treatment burden for patients with multimorbidity that has demonstrated good content validity, construct validity, reliability and responsiveness. It is a useful research tool for assessing the impact of interventions on treatment burden. Trial registration number ISRCTN06180958.

[1]  C. May,et al.  Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden , 2017, Quality of Life Research.

[2]  P. Bower,et al.  Improving the management of multimorbidity in general practice: protocol of a cluster randomised controlled trial (The 3D Study) , 2016, BMJ Open.

[3]  Jody L. Vogelzang,et al.  Health Measurement Scales: A Practical Guide to Their Development and Use , 2015 .

[4]  B. Guthrie,et al.  Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines , 2015, BMJ : British Medical Journal.

[5]  T. Fahey,et al.  Managing patients with multimorbidity in primary care , 2015, BMJ : British Medical Journal.

[6]  Paul Wicks,et al.  Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform , 2014, BMC Medicine.

[7]  Alison Richardson,et al.  Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness , 2014, BMC Health Services Research.

[8]  C. Rand,et al.  Healthcare Task Difficulty Among Older Adults With Multimorbidity , 2014, Medical care.

[9]  P. Bower,et al.  Development of a Multimorbidity Illness Perceptions Scale (MULTIPleS) , 2013, PloS one.

[10]  Jerome Billeter,et al.  Delivering better services for people with long term conditions , 2013 .

[11]  J. Browne,et al.  GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research , 2013, BMJ Open.

[12]  S. Wyke,et al.  Double trouble: the impact of multimorbidity and deprivation on preference-weighted health related quality of life a cross sectional analysis of the Scottish Health Survey , 2013, International Journal for Equity in Health.

[13]  C. Chew‐Graham,et al.  How QOF is shaping primary care review consultations: a longitudinal qualitative study , 2013, BMC Family Practice.

[14]  S. Acaster,et al.  Methods for interpreting change over time in patient-reported outcome measures , 2013, Quality of Life Research.

[15]  C. Salisbury.  Multimorbidity: time for action rather than words. , 2013, The British journal of general practice : the journal of the Royal College of General Practitioners.

[16]  L. McLeod,et al.  ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research , 2013, Quality of Life Research.

[17]  B. Guthrie,et al.  Adapting clinical guidelines to take account of multimorbidity , 2012, BMJ : British Medical Journal.

[18]  Joanne Greenhalgh,et al.  Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations , 2012, Quality of Life Research.

[19]  Martin Fortin,et al.  Managing patients with multimorbidity: systematic review of interventions in primary care and community settings , 2012, BMJ : British Medical Journal.

[20]  P. Bower,et al.  Illness representations in patients with multimorbid long-term conditions: Qualitative study , 2012, Psychology & health.

[21]  C. May,et al.  Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study , 2012, Patient related outcome measures.

[22]  N. Santanello,et al.  Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration , 2012, Quality of Life Research.

[23]  Chris Salisbury,et al.  Multimorbidity: redesigning health care for people who use it , 2012, The Lancet.

[24]  P. Ravaud,et al.  Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions , 2012, BMC Medicine.

[25]  R. Hays,et al.  Content validity of patient-reported outcome measures: perspectives from a PROMIS meeting , 2012, Quality of Life Research.

[26]  W. Gellad,et al.  Medication adherence to multidrug regimens. , 2012, Clinics in geriatric medicine.

[27]  S. Goodman,et al.  Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. , 2012, JAMA.

[28]  A. Bottomley,et al.  The process of reconciliation: evaluation of guidelines for translating quality-of-life questionnaires , 2012, Expert review of pharmacoeconomics & outcomes research.

[29]  F. Angst.  The new COSMIN guidelines confront traditional concepts of responsiveness , 2011, BMC medical research methodology.

[30]  J. Valderas,et al.  The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. , 2011, Family practice.

[31]  C. Terwee,et al.  Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist , 2011, Quality of Life Research.

[32]  A. Abernethy,et al.  Electronic Toxicity Monitoring and Patient-Reported Outcomes , 2011, Cancer journal.

[33]  R. Buchbinder,et al.  Critical appraisal of health literacy indices revealed variable underlying constructs, narrow content and psychometric weaknesses. , 2011, Journal of clinical epidemiology.

[34]  S. Wyke,et al.  An ‘endless struggle’: a qualitative study of general practitioners’ and practice nurses’ experiences of managing multimorbidity in socio-economically deprived areas of Scotland , 2011, Chronic illness.

[35]  Caroline Sanders,et al.  Shifting priorities in multimorbidity: a longitudinal qualitative study of patient’s prioritization of multiple conditions , 2011, Chronic illness.

[36]  C. Terwee,et al.  Inter-rater agreement and reliability of the COSMIN (COnsensus-based Standards for the selection of health status Measurement Instruments) Checklist , 2010, BMC medical research methodology.

[37]  Florence T. Bourgeois,et al.  Adverse drug events in the outpatient setting: an 11‐year national analysis , 2010, Pharmacoepidemiology and drug safety.

[38]  C. Terwee,et al.  The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. , 2010, Journal of clinical epidemiology.

[39]  Tom O'Dowd,et al.  GPs' and pharmacists' experiences of managing multimorbidity: a 'Pandora's box'. , 2010, The British journal of general practice : the journal of the Royal College of General Practitioners.

[40]  L. Mokkink,et al.  The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: A clarification of its content , 2010, BMC medical research methodology.

[41]  C. Terwee,et al.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study , 2010, Quality of Life Research.

[42]  G. Kemmler,et al.  A new approach to combining clinical relevance and statistical significance for evaluation of quality of life changes in the individual patient. , 2010, Journal of clinical epidemiology.

[43]  Pennifer Erickson,et al.  Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[44]  Pennifer Erickson,et al.  A concept taxonomy and an instrument hierarchy: tools for establishing and evaluating the conceptual framework of a patient-reported outcome (PRO) instrument as applied to product labeling claims. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[45]  C. Terwee,et al.  Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments , 2009, Quality of Life Research.

[46]  Elizabeth Molsen,et al.  Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[47]  David Cella,et al.  Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[48]  J. Steiner,et al.  Seniors' self-reported multimorbidity captured biopsychosocial factors not incorporated into two other data-based morbidity measures. , 2009, Journal of clinical epidemiology.

[49]  N. Scott,et al.  EORTC Quality of Life Group translation procedure , 2009 .

[50]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[51]  Elizabeth A Bayliss,et al.  Processes of care desired by elderly patients with multimorbidities. , 2008, Family practice.

[52]  Michael Herdman,et al.  Development of EMPRO: a tool for the standardized assessment of patient-reported outcome measures. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[53]  Catherine Acquadro,et al.  Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[54]  R. Hays,et al.  Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.

[55]  D. Patrick,et al.  Patient-reported outcomes to support medical product labeling claims: FDA perspective. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[56]  Ron D Hays,et al.  What is sufficient evidence for the reliability and validity of patient-reported outcome measures? , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[57]  Charles S Cleeland,et al.  Patient-reported outcomes: instrument development and selection issues. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[58]  Elizabeth A Bayliss,et al.  Barriers to Self-Management and Quality-of-Life Outcomes in Seniors With Multimorbidities , 2007, The Annals of Family Medicine.

[59]  Paul G Shekelle,et al.  Combining Multiple Indicators of Clinical Quality: An Evaluation of Different Analytic Approaches , 2007, Medical care.

[60]  G. Guyatt,et al.  How can quality of life researchers make their work more useful to health workers and their patients? , 2007, Quality of Life Research.

[61]  A. Gnanasakthy,et al.  Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier , 2007, Quality of Life Research.

[62]  R. Hays,et al.  Health and Quality of Life Outcomes , 2006 .

[63]  G. Guyatt,et al.  How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure , 2006, Health and quality of life outcomes.

[64]  G. Guyatt,et al.  Interpreting the results of patient reported outcome measures in clinical trials: The clinician's perspective , 2006, Health and quality of life outcomes.

[65]  G. Watt,et al.  Relevance and practical use of the Consultation and Relational Empathy (CARE) Measure in general practice. , 2005, Family practice.

[66]  R. Glasgow,et al.  Development and Validation of the Patient Assessment of Chronic Illness Care (PACIC) , 2005, Medical care.

[67]  G. Guyatt,et al.  Commentary--goodbye M(C)ID! Hello MID, where do you come from? , 2005, Health services research.

[68]  D. Wild,et al.  Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[69]  J. Pugh,et al.  Collaborative care needs and preferences of primary care patients with multimorbidity , 2005, Health expectations : an international journal of public participation in health care and health policy.

[70]  M. Donaldson,et al.  Cancer outcomes research. , 2004, Journal of the National Cancer Institute. Monographs.

[71]  Alan Shiell,et al.  Complex interventions: how “out of control” can a randomised controlled trial be? , 2004, BMJ : British Medical Journal.

[72]  John F. Steiner,et al.  Descriptions of Barriers to Self-Care by Persons with Comorbid Chronic Diseases , 2003, The Annals of Family Medicine.

[73]  Ross D Crosby,et al.  Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.

[74]  Silke Schmidt,et al.  Current issues in cross-cultural quality of life instrument development. , 2003, Archives of physical medicine and rehabilitation.

[75]  Kathleenl N. Lohr,et al.  Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.

[76]  G. Guyatt,et al.  Relation of Distribution- and Anchor-Based Approaches in Interpretation of Changes in Health-Related Quality of Life , 2001, Medical care.

[77]  M. Stewart.  Towards a global definition of patient centred care , 2001, BMJ : British Medical Journal.

[78]  P. Bower,et al.  Patient-centredness: a conceptual framework and review of the empirical literature. , 2000, Social science & medicine.

[79]  M. Sprangers,et al.  Integrating response shift into health-related quality of life research: a theoretical model. , 1999, Social science & medicine.

[80]  R. Hays,et al.  Responsiveness to change: an aspect of validity, not a separate dimension , 1992, Quality of Life Research.

[81]  D. Streiner,et al.  Health Measurement Scales: A practical guide to thier development and use , 1989 .

[82]  R. Deyo,et al.  Barriers to the Use of Health Status Measures in Clinical Investigation, Patient Care, and Policy Research , 1989, Medical care.

[83]  H. Kaiser.  The Application of Electronic Computers to Factor Analysis , 1960 .

[84]  Viola Angelini.  Encyclopedia of Quality of Life and Well-Being Research , 2014 .

[85]  A. Michalos,et al.  Methadone treatment for opiate-dependent persons , 2014 .

[86]  B. Guthrie,et al.  Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. , 2013, Age and ageing.

[87]  Ron D. Hays,et al.  The Concept of Clinically Meaningful Difference in Health-Related Quality-of-Life Research , 2012, PharmacoEconomics.

[88]  J. Valderas,et al.  Epidemiology and impact of multimorbidity in primary care: a retrospective cohort study. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[89]  P. Hannaford,et al.  Ascertaining the size of the symptom iceberg in a UK-wide community-based survey. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[90]  C. Terwee,et al.  Quality criteria were proposed for measurement properties of health status questionnaires. , 2007, Journal of clinical epidemiology.

[91]  J Alonso,et al.  BMC Medical Research Methodology BioMed Central Study protocol Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments , 2006 .

[92]  I. Barofsky,et al.  Recommendations on health-related quality of life research to support labeling and promotional claims in the United States , 2004, Quality of Life Research.

[93]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[94]  Brian T. Austin,et al.  Improving outcomes in chronic illness. , 1996, Managed care quarterly.

[95]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[96]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[97]  B. Tabachnick,et al.  Using Multivariate Statistics , 1983 .